cancer lungs: 11 Prognosis

A. Small Cell Lung Cancer (SCLC):
 With a change therapy in the past 15 - 20 years the possibility of life on average (median survival time) who had < 3 months increased to 1 year.
 The possibility Disease Limited group average life up to 1-2 years, while 20% of it remained alive in 2 years.
 30 % died because of local complications of the tumor.
 70 % died of carsinomatosis.
 50 % metastasize to the brain (autopsy)

B. Non-Small Cell Lung Cancer (NSCLC):
 Most important in the prognosis of lung cancer is to determine the stage of the disease.
 Compared with other types of NSCLC, karsinomaskuamosa not as bad as others. In patients who performed surgery, the possibility of life after 5 years was 30 % surgey.  Survival after surgery, 70 % on Occult carcinoma; 35 - 40 % in stage 1; 10 - 15% in stage II and less than 10 % at stage III.
 75 % of squamous carcinoma died of complications torakal, 25 % because of the extra torakal, 2 % of them died because of the central nervous system disorders.
 40 % of adenocarcinoma and large cell carcinoma died of complications torakal, 5 for 55 extra torakal.
 15 % of adenocarcinoma and large cell carcinoma metastatic to the brain and 8 - 9 % die from central nervous system disorders.
 The possibility of life on average tumor metastases patients varies from 6 months to 1 year, where it is highly dependent on performance status (Karnofsky scale), extent of disease, the weight loss in the last 6 months.